Last update Jan. 25, 2022

ATC N06AA: Antidepressants. Non-selective monoamine reuptake inhibitors

Amitriptyline (belonging to ATC N06AA: Antidepressants. Non-selective monoamine reuptake inhibitors):

Increased level of risk

New scientific data have driven the Apilam staff to update the level of risk associated to this product.
Former level of risk, which was Safe. Compatible. Minimal risk for breastfeeding and infant., is now set to Moderately safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.

Level of risk reviewed on Jan. 24, 2022

Suggestions made at e-lactancia are done by APILAM team, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Groups related with ATC N06AA: Antidepressants. Non-selective monoamine reuptake inhibitors

Total visits

9,669

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by La Liga de la Leche de Euskadi

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM